Metabolic regulation of erythrocyte development and disorders
Experimental Hematology · 2024-03 · 131 · 104153
DOI: 10.1016/j.exphem.2024.104153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2024-03. Verfasst von Junhua Lyu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN. Hauptthemen laut MEDLINE: Erythropoiesis, Anemia, Sickle Cell. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The formation of new red blood cells (RBC) (erythropoiesis) has served as a paradigm for understanding cellular differentiation and developmental control of gene expression. The metabolic regulation of this complex, coordinated process remains poorly understood. Each step of erythropoiesis, including lineage specification of hematopoietic stem cells, proliferation, differentiation, and terminal maturation into highly specialized oxygen-carrying cells, has unique metabolic requirements. Developing erythrocytes in mammals are also characterized by unique metabolic events such as loss of mitochondria with switch to glycolysis, ejection of nucleus and organelles, high-level heme and hemoglobin synthesis, and antioxidant requirement to protect hemoglobin molecules. Genetic defects in metabolic enzymes, including pyruvate kinase and glucose-6-phosphate dehydrogenase, cause common erythrocyte disorders, whereas other inherited disorders such as sickle cell disease and β-thalassemia display metabolic abnormalities associated with disease pathophysiology. Here we describe recent discoveries on the metabolic control of RBC formation and function, highlight emerging concepts in understanding the erythroid metabolome, and discuss potential therapeutic benefits of targeting metabolism for RBC disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
- Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
- Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
- Center of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN. Electronic address: jian.xu@stjude.org.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Society of Hematology
- Leukemia and Lymphoma Society
Zitieren
APA
Lyu, J., Ni, M., Weiss, M. J., & Xu, J. (2024). Metabolic regulation of erythrocyte development and disorders. Experimental Hematology, 131, 104153. https://doi.org/10.1016/j.exphem.2024.104153
Vancouver
Lyu J, Ni M, Weiss MJ, Xu J. Metabolic regulation of erythrocyte development and disorders. Experimental Hematology. 2024;131:104153. doi:10.1016/j.exphem.2024.104153
BibTeX
@article{Lyu2024,
author = {Lyu, Junhua and Ni, Min and Weiss, Mitchell J and Xu, Jian},
title = {Metabolic regulation of erythrocyte development and disorders},
journal = {Experimental Hematology},
year = {2024},
volume = {131},
pages = {104153},
doi = {10.1016/j.exphem.2024.104153}
}
EUVIMED